Please assess the completion status of the following clinical trial:

Trial Title: Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* idiopathic RLS with the presence of all four clinical manifestations of RLS~* RLS symptoms occur predominantly in the evening~* RLS history at least 6 months~* IRLS =\> 15 at the beginning and the end of placebo run-in~* Have =\>15 nights with RLS symptoms in the month prior to screening~Exclusion Criteria:~* Any secondary RLS~* Current augmentation due to RLS treatment~* Placebo responders identified during the placebo run-in

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PBO/PGB 300 mg (Type: EXPERIMENTAL): None
- PBO/PPX 0.25 mg (Type: ACTIVE_COMPARATOR): None
- PBO/PPX 0.5 mg (Type: ACTIVE_COMPARATOR): None
- PGB 300 mg (Type: EXPERIMENTAL): None
- PPX 0.25 mg (Type: ACTIVE_COMPARATOR): None
- PPX 0.5 mg (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).